Abstract
Mitral regurgitation is the heart valve disease with the highest prevalence and the second most frequently needing intervention. Primary mitral regurgitation is caused by abnormalities of the mitral valve components, whilst secondary mitral regurgitation is caused by abnormalities of the juxtaposed cardiac chambers, the left ventricle and/or the left atrium. Assessment, prognosis and management of mitral regurgitation depend on the primary or secondary nature of the disease. This chapter describes mitral regurgitation pathogenesis, epidemiology, aetiology, physiopathology, clinical presentation, physical examination, diagnosis and treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dal-Bianco JP, Beaudoin J, Levine RA. Basic mechanisms of mitral regurgitation. Can J Cardiol. 2014;30(9):971–81. https://doi.org/10.1016/j.cjca.2014.06.022.
Carpentier A, Adams DH, Filsoufi F. Carpentier’s reconstructive valve surgery. from valve analysis to valve reconstruction. Philadelphia: Saunders Elsevier; 2010.
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.
Andell P, Li X, Martinsson A, et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart. 2017;103:1696–703.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–43.
Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373(9672):1382–94. https://doi.org/10.1016/S0140-6736(09)60692-9. Epub 2009 Apr 6.
Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341(1):1–7.
Delling FN, Vasan RS. Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation. 2014;129(21):2158–70. https://doi.org/10.1161/CIRCULATIONAHA.113.006702.
Waller BF, Morrow AG, Maron BJ, Del Negro AA, Kent KM, McGrath FJ, Wallace RB, McIntosh CL, Roberts WC. Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J. 1982;104(pt 1):276–88.
Olson L, Subramanian R, Ackermann D, Orszulak T, Edwards W. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc. 1987;62:22–34.
M E-S, Freeman WK, Tribouilloy CM, Orszulak TA, Khandheria BK, Seward JB, Bailey KR, Tajik AJ. Functional anatomy of mitral regurgitation: accuracy and outcome implications of transesophageal echocardiography. J Am Coll Cardiol. 1999;34(4):1129–36.
El Sabbagh A, Reddy YNV, Nishimura RA. Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions. JACC Cardiovasc Imaging. 2018;11(4):628–43. https://doi.org/10.1016/j.jcmg.2018.01.009.
Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births incidence and natural history. Circulation. 1971;43:323–32.
Boudoulas KD, Borer JS, Boudoulas H. Etiology of valvular heart disease in the 21st century. Cardiology. 2013;126(3):139–52. https://doi.org/10.1159/000354221. Epub 2013 Aug 24.
Delling FN, Rong J, Larson MG, Lehman B, Fuller D, Osypiuk E, Stantchev P, Hackman B, Manning WJ, Benjamin EJ, Levine RA, Vasan RS. Evolution of mitral valve prolapse: insights from the Framingham Heart Study. Circulation. 2016;133(17):1688–95. https://doi.org/10.1161/CIRCULATIONAHA.115.020621. Epub 2016 Mar 22.
Enriquez-Sarano M, Basmadjian AJ, Rossi A, Bailey KR, Seward JB, Tajik AJ. Progression of mitral regurgitation: a prospective Doppler echocardiographic study. J Am Coll Cardiol. 1999;34(4):1137–44.
Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S, Simioniuc A, Gullace M, Ghio S, Enriquez-Sarano M, Temporelli PL. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97(20):1675–80.
Goliasch G, Bartko PE, Pavo N, Neuhold S, Wurm R, Mascherbauer J, Lang IM, Strunk G, Hülsmann M. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur Heart J. 2018;39(1):39–46.
Bursi F, Barbieri A, Grigioni F, Reggianini L, Zanasi V, Leuzzi C, Ricci C, Piovaccari G, Branzi A, Modena MG. Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study. Eur J Heart Fail. 2010;12:382–8.
Trivi M, Thierer J, Kuschnir P, Acosta A, Marino J, Guglielmone R, Ronderos R. Echocardiographic predictors of exercise capacity in patients with heart failure and systolic dysfunction: role of mitral regurgitation. Rev Esp Cardiol. 2011;64(12):1096–9.
Ennezat PV, Sylvestre Maréchaux S, Pibarot P, Le Jemtel TH. Secondary mitral regurgitation in heart failure with reduced or preserved left ventricular ejection fraction. Cardiology. 2013;125:110–7.
Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure. Pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol. 2015;65:1231–48.
Gertz ZM, Raina A, Saghy L, Zado ES, Callans DJ, Marchlinski FE, Keane MG, Silvestry FE. Evidence of atrial functional mitral regurgitation due to atrial fibrillation. Reversal with arrhythmia control. J Am Coll Cardiol. 2011;58:1474–81.
Le Tourneau T, Mérot J, Rimbert A, Le Scouarnec S, Probst V, Le Marec H, Levine RA, Schott JJ. Genetics of syndromic and non-syndromic mitral valve prolapse. Heart. 2018;104(12):978–84. https://doi.org/10.1136/heartjnl-2017-312420. Epub 2018 Jan 19.
Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J. 2010;31(16):1958–66. https://doi.org/10.1093/eurheartj/ehq222. Epub 2010 Jul 11.
Anyanwu AC, Adams DH. Etiologic classification of degenerative mitral valve disease: Barlow’s disease and fibroelastic deficiency. Semin Thorac Cardiovasc Surg. 2007;19(2):90–6.
Hjortnaes J, Keegan J, Bruneval P, Schwartz E, Schoen FJ, Carpentier A, Levine RA, Hagège A, Aikawa E. Comparative histopathological analysis of mitral valves in barlow disease and fibroelastic deficiency. Semin Thorac Cardiovasc Surg. 2016;28(4):757–67. https://doi.org/10.1053/j.semtcvs.2016.08.015. Epub 2016 Sep 5.
Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation. 2008;118(22):2298–303. https://doi.org/10.1161/CIRCULATIONAHA.107.755942.
Ahmed MI, Guichard JL, Soorappan RN, Ahmad S, Mariappan N, Litovsky S, Gupta H, Lloyd SG, Denney TS, Powell PC, Aban I, Collawn J, Davies JE, McGiffin DC, Dell’Italia LJ. Disruption of desmin-mitochondrial architecture in patients with regurgitant mitral valves and preserved ventricular function. J Thorac Cardiovasc Surg. 2016;152(4):1059–1070.e2. https://doi.org/10.1016/j.jtcvs.2016.06.017. Epub 2016 Jun 25.
Ehlers KH, Engle MA, Levin AR, Grossman H, Fleming R. Left ventricular abnormality with late mitral insufficiency and abnormal electrocardiogram. Am J Cardiol. 1970;26:333–40.
Liedtke AJ, Gault JH, Leaman DM, Blumenthal MS. Geometry of left ventricular contraction in the systolic click syndrome. Characterization of a segmental myocardial abnormality. Circulation. 1973;47:27–35.
Gooch AS, Vicencio F, Maranhao V, Goldberg H. Arrhythmias and left ventricular asynergy in the prolapsing mitral leaflet syndrome. Am J Cardiol. 1972;29:611–20.
Sriram CS, Syed FF, Ferguson ME, Johnson JN, Enriquez-Sarano M, Cetta F, Cannon BC, Asirvatham SJ, Ackerman MJ. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol. 2013;62:222–30.
Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL, Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14(7):611–44. https://doi.org/10.1093/ehjci/jet105. Epub 2013 Jun 3.
Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71. https://doi.org/10.1016/j.echo.2017.01.007. Epub 2017 Mar 14.
Silbiger JJ. Mechanistic insights into ischemic mitral regurgitation: echocardiographic and surgical implications. J Am Soc Echocardiogr. 2011;24:707–19. https://doi.org/10.1016/j.echo.2011.04.001.
Garbi M, Monaghan MJ. Quantitative mitral valve anatomy and pathology. Echo Res Pract. 2015;2(3):R63–72.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. https://doi.org/10.1016/j.echo.2014.10.003.
Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popović ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61(1):77–84. https://doi.org/10.1016/j.jacc.2012.09.035. Epub 2012 Nov 28.
Kim HM, Cho GY, Hwang IC, Choi HM, Park JB, Yoon YE, Kim HK. Myocardial strain in prediction of outcomes after surgery for severe mitral regurgitation. JACC Cardiovasc Imaging. 2018;11(9):1235–44. https://doi.org/10.1016/j.jcmg.2018.03.016. Epub 2018 May 16.
Le Tourneau T, Messika-Zeitoun D, Russo A, Detaint D, Topilsky Y, Mahoney DW, Suri R, Enriquez-Sarano M. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol. 2010;56(7):570–8. https://doi.org/10.1016/j.jacc.2010.02.059.
Le Tourneau T, Richardson M, Juthier F, Modine T, Fayad G, Polge AS, Ennezat PV, Bauters C, Vincentelli A, Deklunder G. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart. 2010;96(16):1311–7. https://doi.org/10.1136/hrt.2009.186486.
Magne J, Lancellotti P, Piérard LA. Exercise-induced changes in degenerative mitral regurgitation. J Am Coll Cardiol. 2010;56:300–9.
Lancellotti P, Magne J. Stress testing for the evaluation of patients with mitral regurgitation. Curr Opin Cardiol. 2012;27:492–8.
Magne J, Lancellotti P, Pierard LA. Stress echocardiography and mitral valvular heart disease. Cardiol Clin. 2013;31:311–21.
Lancellotti P, Dulgheru R, Go YY, Sugimoto T, Marchetta S, Oury C, Garbi M. Stress echocardiography in patients with native valvular heart disease. Heart. 2017;0:1–7. https://doi.org/10.1136/heartjnl-2017-311682.
Lee R, Haluska B, Leung DY, et al. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart. 2005;91:1407–12.
Magne J, Mahjoub H, Dulgheru R, et al. Left ventricular contractile reserve in asymptomatic primary mitral regurgitation. Eur Heart J. 2014;35:1608–16.
Magne J, Lancellotti P, Piérard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation. 2010;122:33–41.
Lancellotti P, Martinez C, Bernard A. Pulmonary pressures and outcome in primary mitral regurgitation: paradigm shift from rung to ladder. J Am Coll Cardiol. 2016;67:2962–4.
Magne J, Donal E, Mahjoub H, et al. Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation. Heart. 2015;101:391–6.
Piérard LA, Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med. 2004;351:1627–34.
Christiansen JP, Karamitsos TD, Myerson SG. Assessment of valvular heart disease by cardiovascular magnetic resonance imaging: a review. Heart Lung Circ. 2011;20:73–82.
Han Y, Peters DC, Salton CJ, et al. Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging. 2008;1:294–303.
Lancellotti P, Zamorano JL, Vannan MA. Imaging challenges in secondary mitral regurgitation: unsolved issues and perspectives. Circ Cardiovasc Imaging. 2014;7:735–46.
Pontone G, Andreini D, Bertella E, Cortinovis S, Mushtaq S, Foti C, Annoni A, Formenti A, Baggiano A, Conte E, Ballerini G, Fiorentini C, Bartorelli AL, Pepi M. Pre-operative CT coronary angiography in patients with mitral valve prolapse referred for surgical repair: comparison of accuracy, radiation dose and cost versus invasive coronary angiography. Int J Cardiol. 2013;167:2889–94.
Guo YK, Yang ZG, Ning G, et al. Isolated mitral regurgitation: quantitative assessment with 64-section multidetector CT—comparison with MR imaging and echocardiography. Radiology. 2009;252:369–76.
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.
Casselman FP, Van Slycke S, Wellens F, et al. From classical sternotomy to truly endoscopic mitral valve surgery: a step by step procedure. Heart Lung Circ. 2003;12:172–7.
Modi P, Rodriguez E, Hargrove WC III, et al. Minimally invasive videoassisted mitral valve surgery: a 12-year, 2-center experience in 1178 patients. J Thorac Cardiovasc Surg. 2009;137:1481–7.
Chan KM, Punjabi PP, Flather M, et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012;126:2502–10.
Carpentier A. Cardiac valve surgery—the “French correction”. J Thorac Cardiovasc Surg. 1983;86:323–37.
Dreyfus GD, Dulguerov F, Marcacci C, Haley SR, Gkouma A, Dommerc C, Albert A. “Respect when you can, resect when you should”: a realistic approach to posterior leaflet mitral valve repair. J Thorac Cardiovasc Surg. 2018;156(5):1856–66.
Adams DH, Anyanwu AC, Sugeng L, et al. Degenerative mitral valve regurgitation: surgical echocardiography. Curr Cardiol Rep. 2008;10:226–32.
Seeburger J, Kuntze T, Mohr FW. Gore-tex chordoplasty in degenerative mitral valve repair. Semin Thorac Cardiovasc Surg. 2007;19:111–5.
Braunberger E, Deloche A, Berrebi A, et al. Very long-term results (more than 20 years) of valve repair with carpentier’s techniques in nonrheumatic mitral valve insufficiency. Circulation. 2001;104:I8–11.
Kim JB, Kim HJ, Moon DH, et al. Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement. Eur J Cardiothorac Surg. 2010;37:1039–46.
Maisano F, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg. 1998;13(3):240–5. discussion 245–6.
Condado JA, et al. Percutaneous edge-to-edge mitral valve repair: 2-year follow-up in the first human case. Catheter Cardiovasc Interv. 2006;67(2):323–5.
Attizzani GF, et al. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. JACC Cardiovasc Interv. 2015;8(1 Pt A):74–82.
Taramasso M, Maisano F. Challenging mitral clefts with MitraClip: the convergent clips strategy. EuroIntervention. 2016;12(8):e1071.
Singh GD, Smith TW, Rogers TH. Multi-MitraClip therapy for severe degenerative mitral regurgitation: “anchor” technique for extremely flail segments. Catheter Cardiovasc Interv. 2015;86(2):339–46.
Kische S, Nienaber C, Ince H. Use of four MitraClip devices in a patient with ischemic cardiomyopathy and mitral regurgitation: “zipping by clipping”. Catheter Cardiovasc Interv. 2012;80(6):1007–13.
Weinmann K, et al. First experience with MitraClip XTR device for severe mitral valve prolapse (Barlow’s disease). EuroIntervention. 2018;14(12):e1276–7.
Colli A, et al. Prognostic impact of leaflet-to-annulus index in patients treated with transapical off-pump echo-guided mitral valve repair with NeoChord implantation. Int J Cardiol. 2018;257:235–7.
Colli A, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. Eur J Cardiothorac Surg. 2018;54(3):460–6.
Kuwata S, et al. Transcatheter mitral annuloplasty in Barlow’s mitral regurgitation with deep cleft. JACC Cardiovasc Interv. 2018;11(12):e97–8.
Brustle K, et al. Transcatheter mitral annuloplasty to treat residual mitral regurgitation after MitraClip implantation. EuroIntervention. 2017;13(8):912–3.
Muller DWM, et al. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol. 2017;69(4):381–91.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der MP, Authors/Task Force Members. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129–200.
Bartko PE, Dal-Bianco JP, Guerrero JL, Beaudoin J, Szymanski C, Kim D-H, Seybolt MM, Handschumacher MD, Sullivan S, Garcia ML, Titus JS, Wylie-Sears J, Irvin WS, Messas E, Hagège AA, Carpentier A, Aikawa E, Bischoff J, Levine RA, Network LTM. Effect of losartan on mitral valve changes after myocardial infarction. J Am Coll Cardiol. 2017;70:1232–44.
Kang D-H, Park S-J, Shin S-H, Hong G-R, Lee S, Kim M-S, Yun S-C, Song J-M, Park S-W, Kim J-J. Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation. Circulation. 2019;139:1354–65.
Aklog L, Filsoufi F, Flores F, Chen RH, Cohn LH, Nathan NS, Byrne JG, Adams DH. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation. 2001;104:68–75.
Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack M, Demers P, Atluri P, Rose EA, O’Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O’Gara PT, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344–53.
Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, Acker MA, Hung JW, Chang HL, Perrault LP, Gillinov AM, Argenziano M, Bagiella E, Overbey JR, Moquete EG, Gupta LN, Miller MA, Taddei-Peters WC, Jeffries N, Weisel RD, Rose EA, Gammie JS, DeRose JJ, Puskas JD, Dagenais F, Burks SG, El-Hamamsy I, Milano CA, Atluri P, Voisine P, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374:1932–41.
Acker MA, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370(1):23–32.
Timek TA, Lai DT, Tibayan F, Liang D, Rodriguez F, Daughters GT, Dagum P, Ingels NB Jr, Miller C. Annular versus subvalvular approaches to acute ischemic mitral regurgitation. Circulation. 2002;106(12 Suppl 1):I27–32.
De Bonis M, Lapenna E, Taramasso M, La Canna G, Buzzatti N, Pappalardo F, Alfieri O. Very long-term durability of the edge-to-edge repair for isolated anterior mitral leaflet prolapse: up to 21 years of clinical and echocardiographic results. J Thorac Cardiovasc Surg. 2014;148(5):2027–32.
Maisano F, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62(12):1052–61.
Obadia JF, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297–306.
Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ, Investigators COAPT. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307–18.
Maisano F, et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J. 2016;37(10):817–25.
Goldberg SL, Hammerstingl C. Coronary sinus-based approach to mitral regurgitation. Interv Cardiol Clin. 2016;5(1):93–100.
Rogers JH, et al. Combined MitraClip edge-to-edge repair with millipede IRIS mitral annuloplasty. JACC Cardiovasc Interv. 2018;11(3):323–4.
Yoon SH, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40(5):441–51.
Maisano F, et al. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J. 2015;36(26):1651–9.
Cheung A, et al. Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol. 2014;64(17):1814–9.
Lancellotti P, Pibarot P, Chambers J, et al. Recommendations for the imaging assessment of prosthetic heart valves. Eur Heart J Cardiovasc Imaging. 2016;17(6):589–90.
Stone GW, Adams DH, Abraham WT et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium. Eur Heart J. 2015;36(29):1878–91. doi: https://doi.org/10.1093/eurheartj/ehv333.
Ennezat PV, Sylvestre Maréchaux S, Pibarot P, Le Jemtel TH. Secondary Mitral Regurgitation in Heart Failure with Reduced or Preserved Left Ventricular Ejection Fraction. Cardiology 2013;125:110–117.
Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J. 2010;31(16):1958–66. doi: https://doi.org/10.1093/eurheartj/ehq222.
Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation. 2008;118(22):2298–303. doi: https://doi.org/10.1161/CIRCULATIONAHA.107.755942.
Cohn LH, Tchantchaleishvili V, Rajab TK. Evolution of the concept and practice of mitral valve repair. http://dx.doi.org/10.3978/j.issn.2225-319X.2015.04.09
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Garbi, M., Magne, J., Maisano, F., Swaans, M., Dulgheru, R., Lancellotti, P. (2020). Mitral Regurgitation. In: Zamorano, J., Lancellotti, P., Pierard, L., Pibarot, P. (eds) Heart Valve Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-23104-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-23104-0_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23103-3
Online ISBN: 978-3-030-23104-0
eBook Packages: MedicineMedicine (R0)